CNS arousal systems: possible role in delirium

Area of Science:

• Neuroscience
• Gerontology
• Pharmacology

Background:

• Delirium is traditionally viewed as a global cerebral dysfunction.
• Emerging evidence suggests heterogeneity within delirium syndromes, implicating specific brain systems.
• Neurotransmitter-specific projections from the hypothalamus and brain stem to the cortex are crucial for arousal and attention.

Purpose of the Study:

• To explore the neurophysiological underpinnings of different delirium subtypes.
• To investigate the role of specific neurotransmitter systems in conditions like hepatic encephalopathy and anticholinergic toxicity.
• To examine the impact of aging on these neurochemical systems in relation to delirium.

Main Methods:

• Review of clinical evidence and research findings on brain neurochemical systems.
• Analysis of neurotransmitter pathways implicated in specific delirium types.
• Consideration of age-related changes in neurochemical systems and their link to delirium.

Main Results:

• GABA systems are implicated in hepatic encephalopathy delirium.
• Cholinergic neurons in the basal forebrain and pons may play a role in anticholinergic toxicity delirium.
• Cholinergic system degeneration in Alzheimer's disease patients increases sensitivity to anticholinergic toxicity.

Conclusions:

• Delirium subtypes may be linked to distinct neurochemical system alterations.
• Further research is needed on the physiology of these systems in normal and pathological states, especially concerning aging.
• Understanding these systems could lead to targeted treatments for specific delirium types.